Logo.jpg
Worksport to Present at LD Micro Invitational XI
June 03, 2021 08:00 ET | Worksport Ltd
Presentation on Tuesday, June 8th at 1:30 PM EDT TORONTO, June 03, 2021 (GLOBE NEWSWIRE) -- Worksport Ltd (OTC: WKSP), a real gem being discovered as a household name among sustainable energy...
FM_ClearPath_Logo_Black.png
ClearPath Solutions Launches New Division: ClearPath Franchise Match
June 03, 2021 08:00 ET | ClearPath
NEWPORT BEACH, Calif., June 03, 2021 (GLOBE NEWSWIRE) -- ClearPath Solutions, a nationally-recognized executive search firm that has been successfully matching executives with leadership teams in...
AdImpact_Logo_RGB__Color-Black-e1605315929401.png
AdImpact Taps Nielsen and Deluxe Veteran, Dwight Green as Chief Business Officer
June 03, 2021 08:00 ET | AdImpact
ALEXANDRIA, Va., June 03, 2021 (GLOBE NEWSWIRE) -- AdImpact, a leading competitive ad intelligence SaaS company, has announced that Dwight Green has been appointed as the company’s new Chief...
harsco_in_website_careers.jpg
Harsco Celebrates World Environment Day With Strong Sustainability Milestones Across Divisions
June 03, 2021 08:00 ET | Harsco Corporation
CAMP HILL, Pa., June 03, 2021 (GLOBE NEWSWIRE) -- Harsco makes commitment to champion initiatives solving most difficult global environmental challenges; Company now derives 82-percent of annual...
SeaChangeLogo.png
SeaChange International Sets First Quarter Fiscal 2022 Conference Call for Thursday, June 10 at 5:00 p.m. ET
June 03, 2021 08:00 ET | SeaChange International, Inc.
BOSTON, June 03, 2021 (GLOBE NEWSWIRE) -- SeaChange International, Inc. (NASDAQ: SEAC), a leading provider of video delivery platforms, will hold a conference call on Thursday, June 10, 2021 at 5:00...
Oyster_Point_Social.jpg
Oyster Point Pharma Announces Preclinical Study Results and Pipeline Expansion with Enriched Tear Film (ETF™) Gene Therapy to Target Ocular Surface Diseases
June 03, 2021 08:00 ET | Oyster Point Pharma, Inc.
Introduction of proprietary ETF™ Gene Therapy and first gene candidate, nerve growth factor (NGF), to target Stages 2 and 3 Neurotrophic Keratopathy (NK)Preclinical study results from a 42-day...
Stellanova_Logo.png
Stellanova Therapeutics, Inc. Announces Closing of $15.5 Million Series A Financing
June 03, 2021 08:00 ET | Stellanova Theraputic
HOUSTON, June 03, 2021 (GLOBE NEWSWIRE) -- Stellanova Therapeutics, Inc. (“Stellanova”), a biotechnology company advancing cancer therapies targeting the tumor microenvironment, today announced the...
Nature's Sunshine Logo - Green.jpg
Nature’s Sunshine to Present at the Stifel Cross Sector Insight Conference on June 9th, 2021
June 03, 2021 08:00 ET | Nature's Sunshine Products, Inc.
LEHI, Utah, June 03, 2021 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (NASDAQ: NATR), a leading natural health and wellness company of premium herbal and nutritional products, will be...
MNPR Triangle 2.JPG
Monopar Announces New Drug Candidate, MNPR-202, and Enters into Collaboration Agreement with the National University of Singapore for Preclinical Evaluation in Cancer
June 03, 2021 08:00 ET | Monopar Therapeutics Inc.
WILMETTE, Ill., June 03, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics...
Equillium_Square_Logo.png
Equillium to Host Conference Call Following Presentation of Data from the EQUATE Study in Acute Graft Versus Host Disease at the EHA2021 Virtual Congress of the European Hematology Association on June 11
June 03, 2021 08:00 ET | Equillium
Presentation and conference call will include topline data from all cohorts The risk-benefit profile observed supports advancing development of itolizumab in first-line therapy LA JOLLA,...